Toyota|$17.90 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$24.74 (¥3,909)-1.21%▼ (in JPY terms)
SoftBank|$29.93 (¥4,729)+1.00%▲ (in JPY terms)
MUFG|$21.73 (¥3,434)+1.69%▲ (in JPY terms)
Keyence|$491.81 (¥77,720)-1.86%▼ (in JPY terms)
Nintendo|$51.66 (¥8,163)-1.78%▼ (in JPY terms)
NTT|$1.08 (¥171)-0.35%▼ (in JPY terms)
Takeda|$40.11 (¥6,339)+0.51%▲ (in JPY terms)
Tokyo Electron|$61.96 (¥9,791)-0.14%▼ (in JPY terms)
Recruit|$119.00 (¥18,805)+0.03%▲ (in JPY terms)
ITOCHU|$14.60 (¥2,307)-0.17%▼ (in JPY terms)
Honda|$11.22 (¥1,773)+0.57%▲ (in JPY terms)
Shin-Etsu|$37.87 (¥5,985)-0.32%▼ (in JPY terms)
Tokio Marine|$3.54 (¥559)+0.74%▲ (in JPY terms)
Fast Retailing|$462.58 (¥73,100)-0.57%▼ (in JPY terms)
Toyota|$17.90 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$24.74 (¥3,909)-1.21%▼ (in JPY terms)
SoftBank|$29.93 (¥4,729)+1.00%▲ (in JPY terms)
MUFG|$21.73 (¥3,434)+1.69%▲ (in JPY terms)
Keyence|$491.81 (¥77,720)-1.86%▼ (in JPY terms)
Nintendo|$51.66 (¥8,163)-1.78%▼ (in JPY terms)
NTT|$1.08 (¥171)-0.35%▼ (in JPY terms)
Takeda|$40.11 (¥6,339)+0.51%▲ (in JPY terms)
Tokyo Electron|$61.96 (¥9,791)-0.14%▼ (in JPY terms)
Recruit|$119.00 (¥18,805)+0.03%▲ (in JPY terms)
ITOCHU|$14.60 (¥2,307)-0.17%▼ (in JPY terms)
Honda|$11.22 (¥1,773)+0.57%▲ (in JPY terms)
Shin-Etsu|$37.87 (¥5,985)-0.32%▼ (in JPY terms)
Tokio Marine|$3.54 (¥559)+0.74%▲ (in JPY terms)
Fast Retailing|$462.58 (¥73,100)-0.57%▼ (in JPY terms)

2026-04-21 Eisai Co.,Ltd. “An update on the Phase III clinical trial "LITESPARK-012," which evaluates combination therapy as a first-line treatment for patients with advanced renal cell carcinoma (RCC).”

2026-04-21 Eisai Co.,Ltd. “An update on the Phase III clinical trial "LITESPARK-012," which evaluates combination therapy as a first-line treatment for patients with advanced renal cell carcinoma (RCC).”

コメントする